I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Nakae, Kazuto
19
results:
Search for persons
X
Format
Online (19)
Mediatypes
Articles (Online) (8)
OpenAccess-fulltext (11)
Sorted by: Relevance
Sorted by: Year
?
1
Potential application of measuring serum infliximab levels ..:
Nakae, Kazuto
;
Masui, Sho
;
Yonezawa, Atsushi
...
PLOS ONE. 16 (2021) 10 - p. e0258601 , 2021
Link:
https://doi.org/10.1371/..
?
2
Pars plana vitrectomy and panretinal photocoagulation combi..:
Kiuchi, Yoshiaki
;
Nakae, Kazuto
;
Saito, Yoshihiro
..
Graefe's Archive for Clinical and Experimental Ophthalmology. 244 (2006) 12 - p. 1627-1632 , 2006
Link:
https://doi.org/10.1007/..
?
3
Better success of retinal reattachment with long-standing g..:
Uemoto, Riyo
;
Saito, Yoshihiro
;
Sato, Shigeru
...
Graefe's Archive for Clinical and Experimental Ophthalmology. 241 (2003) 10 - p. 792-796 , 2003
Link:
https://doi.org/10.1007/..
?
4
Complete epiretinal membrane separation in highly myopic ey..:
Oshima, Yusuke
;
Ikuno, Yasushi
;
Motokura, Masanobu
..
American Journal of Ophthalmology. 126 (1998) 5 - p. 669-676 , 1998
Link:
https://doi.org/10.1016/..
?
5
ERM, a PEA3 Subfamily of Ets Transcription Factors, Can Coo..:
Nakae, Kazuto
;
Nakajima, Koichi
;
Inazawa, Johji
..
Journal of Biological Chemistry. 270 (1995) 40 - p. 23795-23800 , 1995
Link:
https://doi.org/10.1074/..
?
6
Potential application of measuring serum infliximab levels ..:
Kazuto Nakae
;
Sho Masui
;
Atsushi Yonezawa
...
https://doi.org/10.1371/journal.pone.0258601. , 2021
Link:
https://doi.org/10.1371/..
?
7
Baseline demographics and clinical characteristics of the p..:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/dataset/Baseline_demographics_and_clinical_characteristics_of_the_patients_/16804758. , 2021
Link:
https://doi.org/10.1371/..
?
8
Number of responders and non-responders at maximum effect a..:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/journal_contribution/Number_of_responders_and_non-responders_at_maximum_effect_and_measurement_points_in_High_Low-IFX_group_/16804737. , 2021
Link:
https://doi.org/10.1371/..
?
9
Baseline demographics and clinical characteristics of the p..:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/journal_contribution/Baseline_demographics_and_clinical_characteristics_of_the_patients_in_total_and_study_cohort_/16804734. , 2021
Link:
https://doi.org/10.1371/..
?
10
Comparison of serum IFX levels between ADA positive group (..:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/figure/Comparison_of_serum_IFX_levels_between_ADA_positive_group_ADA_and_negative_group_ADA_-_/16804755. , 2021
Link:
https://doi.org/10.1371/..
?
11
Flowchart on patient inclusion and exclusion:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/figure/Flowchart_on_patient_inclusion_and_exclusion_/16804743. , 2021
Link:
https://doi.org/10.1371/..
?
12
Changes in (A) CDAI, (B) SDAI, (C) CRP, and (D) HAQ-DI from..:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/figure/Changes_in_A_CDAI_B_SDAI_C_CRP_and_D_HAQ-DI_from_the_baseline_to_the_IFX_measurement_point_/16804752. , 2021
Link:
https://doi.org/10.1371/..
?
13
Number (percentages) of responders and non-responders at ma..:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/dataset/Number_percentages_of_responders_and_non-responders_at_maximum_effect_and_measurement_point_in_each_group_/16804764. , 2021
Link:
https://doi.org/10.1371/..
?
14
DAS28-ESR values and serum IFX concentrations in responders..:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/figure/DAS28-ESR_values_and_serum_IFX_concentrations_in_responders_and_non-responders_/16804749. , 2021
Link:
https://doi.org/10.1371/..
?
15
Clinical efficacy of IFX:
Kazuto Nakae (11559141)
;
Sho Masui (11559144)
;
Atsushi Yonezawa (784929)
...
https://figshare.com/articles/figure/Clinical_efficacy_of_IFX_/16804746. , 2021
Link:
https://doi.org/10.1371/..
1-15